<scp>TMEM115</scp> as an Oncogenic and Immunological Biomarker in Hepatocellular Carcinoma
Our findings show TMEM115 as a promising prognostic indicator for HCC and hold promise in predicting responses to immune therapy, emphasising its potential clinical relevance and intricate involvement in the immune microenvironment of HCC.
Authors
- Lei Yang (ORCID: https://orcid.org/0000-0001-5386-8434)
- Ping‐Ping Sun (ORCID: https://orcid.org/0000-0002-2772-2631)
- Lei Chen (ORCID: https://orcid.org/0000-0002-9380-9559)
- Bing Lu (ORCID: https://orcid.org/0000-0002-2141-1322)
- Chengfeng Guo (ORCID: https://orcid.org/0000-0002-5583-6388)
- Jianfei Huang (ORCID: https://orcid.org/0000-0002-1276-5962)
- Xiaojing Zhang (ORCID: https://orcid.org/0000-0001-7032-7154)
- Haiyan Xu
Institutions
- University of Electronic Science and Technology of China (CN)
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Liver International
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1111/liv.70048
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Science and Technology Project of Nantong City